Intra-Cellular Therapies Inc (ITCI)
68.80
-1.54
(-2.19%)
USD |
NASDAQ |
May 03, 16:00
68.82
+0.02
(+0.02%)
After-Hours: 20:00
Intra-Cellular Therapies Price to Book Value: 11.26 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 11.26 |
May 02, 2024 | 11.51 |
May 01, 2024 | 11.90 |
April 30, 2024 | 11.75 |
April 29, 2024 | 11.83 |
April 26, 2024 | 11.99 |
April 25, 2024 | 11.81 |
April 24, 2024 | 11.97 |
April 23, 2024 | 12.11 |
April 22, 2024 | 12.20 |
April 19, 2024 | 11.85 |
April 18, 2024 | 11.79 |
April 17, 2024 | 12.55 |
April 16, 2024 | 13.07 |
April 15, 2024 | 10.60 |
April 12, 2024 | 10.78 |
April 11, 2024 | 11.13 |
April 10, 2024 | 11.01 |
April 09, 2024 | 11.23 |
April 08, 2024 | 11.08 |
April 05, 2024 | 11.20 |
April 04, 2024 | 11.00 |
April 03, 2024 | 11.02 |
April 02, 2024 | 10.91 |
April 01, 2024 | 11.17 |
Date | Value |
---|---|
March 28, 2024 | 11.33 |
March 27, 2024 | 11.41 |
March 26, 2024 | 11.02 |
March 25, 2024 | 11.13 |
March 22, 2024 | 11.30 |
March 21, 2024 | 11.19 |
March 20, 2024 | 11.00 |
March 19, 2024 | 10.71 |
March 18, 2024 | 10.70 |
March 15, 2024 | 10.60 |
March 14, 2024 | 10.57 |
March 13, 2024 | 10.67 |
March 12, 2024 | 10.54 |
March 11, 2024 | 10.71 |
March 08, 2024 | 11.05 |
March 07, 2024 | 10.92 |
March 06, 2024 | 10.81 |
March 05, 2024 | 10.90 |
March 04, 2024 | 11.00 |
March 01, 2024 | 11.70 |
February 29, 2024 | 11.38 |
February 28, 2024 | 11.64 |
February 27, 2024 | 11.93 |
February 26, 2024 | 11.71 |
February 23, 2024 | 11.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.612
Minimum
Sep 27 2019
13.91
Maximum
Mar 29 2022
6.369
Average
6.544
Median
Oct 17 2022
Price to Book Value Benchmarks
Johnson & Johnson | 5.131 |
Insmed Inc | -- |
Vertex Pharmaceuticals Inc | 5.893 |
Fate Therapeutics Inc | 1.094 |
ADMA Biologics Inc | 11.49 |
Price to Book Value Related Metrics
PS Ratio | 14.27 |
Price | 68.80 |
Earnings Yield | -2.12% |
Market Cap | 6.660B |